Increased apoptosis of neutrophils in induced sputum of COPD patients  by Makris, Demosthenes et al.
Respiratory Medicine (2009) 103, 1130e1135ava i lab le a t www.sc iencedi rec t .com
journa l homepage : www.e lsev ie r . com/ loca te / rmedIncreased apoptosis of neutrophils in induced
sputum of COPD patientsDemosthenes Makris a,*, Thomas Vrekoussis b, Mbouloukaki Izoldi a,
Kalogeraki Alexandra b, Darivianaki Katerina b, Tamiolakis Dimitris b,
Alexandrakis Michalis c, Eleni Tzortzaki a, Nikos M. Siafakas a,
Nikos Tzanakis a,da Department of Thoracic Medicine, University of Crete, Medical School, Heraklion, Crete, Greece
b Laboratory of Pathology, University of Crete, Medical School, Heraklion, Crete, Greece
c Department of Hematology, University of Crete, Medical School, Heraklion, Crete, Greece
d Department of Epidemiology, Social Medicine, Medical School, University of Crete, Heraklion, Crete, Greece
Received 9 July 2008; accepted 2 March 2009





Neutrophil* Corresponding author. Tel.: þ30 2
E-mail address: appollon7@hotmai
0954-6111/$ - see front matter ª 200
doi:10.1016/j.rmed.2009.03.002Summary
Aim: The aim of the current study was to evaluate apoptosis in induced sputum neutrophils
and to investigate the relationship between the number of apoptotic cells and clinical param-
eters in COPD patients.
Methods: Twenty-four COPD ex-smoker patients and 10 healthy controls were included in the
study. All subjects underwent clinical evaluation and sputum induction. Sputum cell in situ
apoptosis was identified using white light microscopy and TUNEL assay technique. Apoptosis
of neutrophils obtained by sputum induction was expressed as apoptotic rate (ARZ percen-
tage of apoptotic neutrophils over the number of neutrophils measured).
Results: TUNEL assay revealed statistically significant higher AR in COPD patients than controls
(pZ 0.004). Patients with FEV1 < 50%pred had significantly higher median (IQR) AR (%)
compared to patients with FEV1 50% [26.3 (16e29) vs 13.1 (8.6e21), pZ 0.01]. No significant
association was found between the number of apoptotic cells and age, symptoms or medica-
tion used.
Conclusion: The significantly increased apoptotic rate of neutrophils that were found in COPD
patients with advanced disease compared to controls might reflect either a deregulation of
apoptosis of neutrophils or, a reduced clearance of apoptotic neutrophils from the airways.
The pathophysiologic significance of the observed phenomenon has to be further explored.
ª 2009 Elsevier Ltd. All rights reserved.810 392433/2410 681267.
l.com (D. Makris).
9 Elsevier Ltd. All rights reserved.
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Chronic obstructive pulmonary disease (COPD) is charac-
terized by an abnormal airway inflammation.1 Previous
investigations underlined that airway inflammatory cells
may be implicated in the complex pathogenesis of the
disease, although the exact role of each cell is still under
investigation.2,3 Sputum induction studies have shown that
neutrophils predominate in the airways of COPD patients.4
It could be hypothesized that an inhibition of apoptosis of
airway neutrophils that is essential for the clearance of the
airways from neutrophils and for the resolution of inflam-
mation, might lead in airway neutrophilia and thus in
secondary necrosis of neutrophils and release of their
granule contents into the extracellular environment. In this
respect, a deregulation of apoptosis of neutrophils could be
clinically important leading to excessive proteolytic activity
and resulting in potential tissue damage.5,6
Rytila etal.7 have recentlyaddressed thequestionwhether
airway neutrophilia is associated with inhibition of apoptosis
of airway neutrophils and thus prolonged survival of neutro-
phils due to the presence of pro-neutrophil factors in the
airways. However, the authors found no difference between
COPD patients and controls to support the hypothesis of
deregulation of apoptosis of neutrophils in COPD. Neverthe-
less, the population in that study comprised active smokers
with mild COPD. In this respect the authors underlined that
dysregulation of apoptosis cannot be ruled out in advanced
COPD where airway inflammation is augmented.7
In the present prospective investigation we hypothe-
sized that the apoptosis of airway neutrophils is decreased
in patients with advanced COPD compared to controls. We,
therefore, aimed to assess the apoptotic rates of induced
sputum neutrophils in clinically stable ex-smoker patients
with COPD of variable severity and healthy nonsmoker
controls. In addition, we investigated the relationship
between the apoptotic rate of neutrophils and various




This was a prospective cross-sectional study. Consecutive
sampling was used to recruit 24 patients with a diagnosis of
COPD,8 from a community based outpatient clinic of
University of Crete, Greece. In addition, 10 healthy
nonsmoking subjects were recruited as controls. A history
of bronchial asthma or other respiratory diseases or the
continuous use of systemic steroids for more than 30 days in
the previous year were used as exclusion criteria. Subjects
were also free from COPD exacerbation and received no
antibiotic therapy or oral steroids in the month preceding
the study. The study was approved by the ethics committee
of the local health authority and the patients provided
their consent.
All subjects underwent an initial clinical assessment
during which symptoms were assessed and current medi-
cation were recorded. This was followed by a second visit
one week later for spirometry and sputum induction.Spirometry
Post-bronchodilation spirometry was performed following
premedication with 200 mg salbutamol via metered-dose
inhaler, according to standardized guidelines9 (Lab, 2.12;
Jaeger; Wuerzburg, Germany).
Sputum induction
Sputum was induced via inhalation of a hypertonic
saline aerosol, generated by an ultrasonic nebulizer (Ultraneb
2000; DeVilbiss, Somerset, PA, USA). A previously described
procedure was followed for sputum induction, processing,
total cell counting, and differential cell counting.10 Briefly,
sputum was induced via inhalation of a hypertonic saline
solution aerosol, generated by an ultrasonic nebulizer
(Ultraneb 2000; DeVilbiss; Somerset, PA). The viscid portions
of the expectorated sample were separated from the sputum
and processed within 15 min after termination of the induc-
tion. The weight of the plugs was determined, and dithio-
threitol 0.1% (Sputolysin; Calbiochem; La Jolla, CA) in
phosphate-buffered saline solution was added at a rate of
2 mL to 1 g of the sputumplugs. The sampleswere agitated on
a vortex mixer and placed in a shaking water bath to ensure
complete homogenization. Subsequently, RPMI-1640 plus 10%
fetal calf serum (FCS) was added in a volume twice that of the
homogenized sample and samples were filtered through 48-
mmnylon gauze (Thompson;ON, Canada). A total cell count of
the filtered sample was performed and viability was tested by
means of the trypan blue exclusion staining (SigmaeAdrich
Corporaten; St. Louis,MO) inaNeubauer hemacytometer. The
suspension was then centrifuged at 400g for 5 min, and
the pellet was resuspended with RPMI-1640 and 10% FCS. The
samples were adjusted to a concentration of 0.35 106 cells
per millilitre and 50 mL of the cell suspension was centrifuged
by an aerospray cytocentrifuge (Wescor; Claremont, ON,
Canada) at 300 revolutions per minute with low deceleration
for 5 min. Five hundred nonsquamous cells in coded Maye
GiemsaeGrunwald cytospins were counted in a blinded
fashion by two independent investigators and averaged. In all
cases 500 nonsquamous cells were counted and results were
expressed as the percentage of total nonsquamous cells.
Absolute cell numbers were calculated bymultiplying the cell
percentage by the total cell number in the sputum, divided by
the weight of the selected sputum sample.
In situ detection of apoptotic cells
TUNEL assay is a technique which has been widely used to
identify apoptosis in situ in different cell lines.11,12 It
detects the presence of 30OH-free DNA ends associated with
the DNA fragmentation that characterizes the late phase of
the apoptotic process. In our study, we used a commercial
cell death assay system (In Situ Cell Death Detection kit,
AP, Roche, IN, USA). Briefly, sputum cells were fixed over-
night in 10% paraformaldehyde, dehydrated, and mounted
in paraffin according to standard protocols. The slides were
treated with proteinase K for 15 min at 37 C and, subse-
quently, with 3% hydrogen peroxide for 10 min at 37 C. The
slides were then incubated for 30 min at 37 C in the
presence of the buffer containing the enzyme and dUTP-
Table 1 Baseline characteristics of all 25 COPD patients
and 10 healthy nonsmoker controls.
COPD, nZ 24 Controls, nZ 10
Age, yrs 68 (62e74)a 39 (31e47)
Male/female 20/4 8/2
Pack-years 45 (27e18)a 0 (0)b
Duration of illness 6 (2) na
FEV1, ml 1190 (860e1610)
a 3450 (2890e3580)
FEV1, %pred 48 (31e65)
a 92 (88e101)
FEV1/FVC (%) 52 (45e61)
a 90 (88e97)
Chronic cough, n (%) 12 (52)a 0 (0)
Chronic sputum, n (%) 9 (39)a 0 (0)
MRC 2 (1e3)a 0 (0e1)
6MWT, m 356 (245e385) na
Inhaled steroids, n (%)b 14 (58)a 0 (0)
Inhaled LABA, n (%)b 14 (58)a 0 (0)
COPDZ chronic obstructive pulmonary disease; FEV1Z forced
expiratory volume in 1 s; and MRCZMedical Research Council.
Continuous data are expressed as median (IQR) unless otherwise
indicated.
a Difference between smokers and ex-smokers with COPD,
p< 0.05.
b Continuous treatment during the last two months.
1132 D. Makris et al.biotin, followed by 30 min at 37 C with the solution con-
taining alkaline phosphatase-conjugated streptavidin and,
finally, 30 min at 37 C with the substrate solution.
Apoptotic cells appeared with a brown nucleus due to the
hematoxylin counterstaining. The apoptotic rate (AR) was
expressed as the percentage of apoptotic neutrophils over
the overall number of neutrophils. Two cytospins for each
patient were screened. The mean value between two
observers was used for analysis.
Light microscopy
Five hundred cells were counted and morphologically
evaluated by microscopy. Apoptotic neutrophils were
differentiated on the basis of nuclear condensation,
nuclear coalescence and cytoplasmic shrinkage as
described previously.13 All counts were performed on coded
cytospins by two investigators blinded to the clinical char-
acteristics of the subjects. Two cytospins for each patient
were screened. The apoptotic rate was expressed as the
percentage of apoptotic neutrophils over the overall
number of neutrophils. The mean value between two
observers was used for analysis.
TNF-a cytokine assay
TNF-a levels are significantly increased in the airways of
COPD patients and have the ability to induce apoptosis in
human neutrophils.14,15 Thus, we measured TNF-a levels in
sputum supernatant using a high sensitivity ELISA kit (R&D
Systems, Minneapolis, MN). The reproducibility of these
assays was confirmed by performing repeated measure-
ments on successive days. The intraclass coefficient (R) for
both measurements was between 0.92 and 0.98. Investi-
gators performing the cytokine assays were kept blinded to
the sequence of the sputum specimens.
Statistical analysis
Differences between groups were examined using the
ManneWhitney U-test for non-normally and the indepen-
dent unpaired t-test for normally distributed data. The
Spearman rank correlation coefficient for non-normally or
the Pearson correlation coefficient for normally distributed
data were calculated to assess correlations between
apoptotic indices and clinical parameters. SPSS statistical
software package (SPSS Inc., Chicago, IL, USA; version 11.0)
was used for analysis. A p-value< 0.05 was considered
statistically significant.
Results
Baseline characteristics of patients and controls are shown in
Table 1. Patientswere all ex-smokers who had quit smoking at
least one year before study entry. The mean (SE) post-bron-
chodilator forced expiratory volume in 1 s (FEV1) (%pred.) of
COPD patients was 46 (4) %. According to the GOLD staging of
disease severity, 4 (16%) patientswere at stage I, 6 (25%) were
at stage II, 8 (33%)wereat stage III and6 (25%)wereat stage IV.
All but one subject enrolled in the study produced
adequate sputum samples. The viability of the cells(percentage of total) in induced sputum did not differ
between COPD patients and controls (pZ 0.7). The total
nonsquamous cell count (106 cells per mg) median (mine
max) was significantly higher in patients than in control
subjects [4.9 (1.5e7) vs 1.2 (0.4e2.1), pZ 0.0001)]. The
percentage of neutrophils were significantly higher in COPD
patients compared to controls and significantly lower
percentage of macrophages were found in patients with
COPD compared to controls (Table 2).
Sputum induction and apoptotic rates
The apoptotic rates (ARs) of neutrophils in induced sputum in
COPD patients and controls using TUNEL are shown in Fig. 1.
The median (IQR) AR (%) was significantly higher in COPD
patients than in controls [19.5 (12.4e29.2) vs 11.2 (9.6e11.7),
pZ 0.004]. Patients with FEV1< 50%pred had significantly
higherARcompared topatientswith FEV1> 50% [26.3 (16e29)
vs13.1 (8.6e21),pZ 0.01] (Fig. 2).Themedian(IQR)AR(%)by
morphologic criteria using light microscopy was also found
higher in COPD patients than in controls [17.6 (14.1e21.5) vs
12.1 (11.2e14.3), pZ 0.01]. Patients with FEV1< 50%pred
had significantly higher AR compared to patients with
FEV1> 50% [19.4 (16.2e21) vs 12.4 (10e13.6), pZ 0.02]. The
correlation between TUNEL and microscopy for the assess-
ment of AR of neutrophils was rZ 0.78, pZ 0.001.
No significant association between apoptotic rates and
age, symptoms, medication used or pack-years was found.
The apoptotic rates of other cells (lymphocytes and
macrophages) were not significantly different between
patients and controls.
TNF-a concentrations
TNF-a (pg/ml) in sputum supernatants was found signifi-
cantly increased in COPD patients compared to controls
Table 2 Sputum cell counts in 24 COPD patients who underwent successfully sputum induction and healthy nonsmoker
controls.
COPD, nZ 24 Healthy controls, nZ 10 p-Value
Total cells sampled (106/mg of sputum) 6.23 (1.91e8.85) 1.32 (0.41e2.35) <0.001
Total viable cells (106/mg of sputum) 5.71 (1.78e8.05) 1.207 (0.40e2.11) n/a
% Of total cells sampled 91.6 (77.8e98.5) 94 (82.5e99.2) ns
Total viable nonsquamous cells (106/mg of sputum) 4.89 (1.5e7) 1.19 (0.4e2.1) n/a
% Of total viable cells 85 (71.4e92.7) 88 (76.2e95.6) ns
Neutrophils (106/mg of sputum) 3.19 (0.97e4.56) 0.48 (0.16e0.84) <0.001
% Of total viable nonsquamous cells 65.2 (46.7e74.5) 41.2 (32e64.5) 0.001
Macrophages (106/mg of sputum) 1.52 (0.46e2.18) 0.65 (0.22e1.16) <0.001
% Of total viable nonsquamous cells 30.8 (46.7e74.5) 56.1 (44.2e66.8) <0.001
Lymphocytes (106/mg of sputum) 0.10 (0.03e0.14) 0.02 (0.007e0.03) ns
% Of total viable nonsquamous cells 2.6 (0.4e4.7) 2.1 (1.4e3.7) ns
Eosinophils (106/mg of sputum) 0.06 (0.02e0.09) 0.01 (0.006e0.04) ns
% Of total viable nonsquamous cells 1.2 (0e4.2) 2 (0e3) ns
Data are expressed as median (minemax). pZ Difference between patients and controls.
Figure 1 Apoptotic rates of sputum neutrophils in COPD
patients and controls.
Sputum cell apoptosis in COPD 1133[290 (220e385) vs 178 (12e281), p< 0.001]. The correlation
between TNF-a levels and AR was rZ 0.42, pZ 0.07.
Discussion
The present investigation suggests that apoptotic neutro-
phils are present in increased rates in the airways of
patients with stable COPD compared to healthy subjects.
The apoptotic rate (AR) was found to be associated with the
severity of airflow obstruction. Patients with more
advanced disease (baseline FEV1< 50%pred) were found to
present a significantly higher apoptotic rate than those with
milder disease. These findings suggest a deregulation of
apoptosis in patients with advanced COPD and might reflect
a defective apoptotic clearance from the airways of COPD
patients.
Recent studies suggested that apoptosis can be
measured in sputum cells and useful information can be
obtained.3,11,16 However, data on sputum neutrophils
apoptosis in stable COPD are sparse.6,7 In this respect, we
assessed apoptosis in sputum cells in patients with stable
COPD providing evidence for the underlying mechanisms of
COPD pathophysiology. Previous studies have shown that
the percentage of apoptotic neutrophils can be measured
reliably using morphologic criteria on cytospin prepara-
tions17 and apoptosis evaluation of neutrophils by nuclear
morphology has shown a high correlation with other
methods of apoptosis evaluation.18 We therefore, assessed
changes in nuclear morphology due to chromatin conden-
sation and fragmentation, using light microscopy and the in
situ nick end labelling method of TUNEL, demonstrating
good agreement between the two different assays.
Our results suggest that apoptosis might be altered in
the airways of patients with advanced COPD. We detected
significantly different apoptotic rates in COPD ex-smoker
patients compared to controls. In addition, despite that
there was no statistically significant correlation between
the apoptotic rate of neutrophils and baseline FEV1, when
we analyzed further the relationship between the
apoptotic rate and the baseline FEV1 we found that patients
with severe disease (FEV1< 50%pred) showed significantlyhigher AR compared to patients with mild disease or
controls (Fig. 2). In addition patients with FEV1> 50%pred
had not significantly different median (IQR) AR compared to
healthy controls. These findings might indicate a deregula-
tion of mechanisms controlling apoptosis in COPD.
However, our results should be interpreted with caution
because we have studied a relatively homogenous pop-
ulation of COPD patients, they were all white Greeks living
in an island, ex-smokers and in the vast majority, male.
Therefore, the conclusions drawn in the present investi-
gation should be rather applied to male COPD patients ex-
smokers than to the general COPD population.
A recent investigation assessed apoptosis in sputum cells
and supernatants of COPD patients but reported no signif-
icant differences in apoptosis and anti-apoptotic activity of
neutrophils between patients and controls. However, there
were differences in methods and population studied
between our investigation and the aforementioned study
Figure 2 Apoptotic rates of sputum neutrophils in COPD
patients according to disease severity and controls.
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with more advanced disease [median (IQR) 48% FEV1pred]
whereas Rytila et al.7 studied a population with mild COPD
(8 out of 14 subjects had COPD of severity stage 0, the
average FEV1 was 78%pred). In addition, the latter study
included current smokers subjects and controls whereas we
studied ex-smokers. Notably, previous investigations have
shown that cigarette smoke inhibits neutrophil apoptosis.19
Therefore, these differences in the populations studied
(disease severity and smoking status) might explain the
different results regarding the rate of neutrophil apoptosis.
The present investigation underlines that a deregulation
of mechanisms controlling apoptosis and clearance of
neutrophils in the airways is likely to occur in patients with
severe airway obstruction. This finding may reflect either
an abnormally increased induction of apoptosis that results
in increased number of apoptotic neutrophils compared to
controls or a reduced clearance of apoptotic neutrophils
from the airways in advanced COPD. The first hypothesis is
supported by a number of studies that reported increased
induction of apoptosis in the inflammatory milieu of the
airway in COPD patients. Apoptotic processes are acceler-
ated in the lung areas of COPD patients with excessive
oxidative stress which in turn, can increase the expression
and mitochondrial translocation of proapoptotic fac-
tors.14,20e22 Inflammatory factors such as TNF-a which are
significantly increased in the airways of COPD patients with
advanced disease have the ability to induce apoptosis in
human neutrophils.15 Apoptosis can be also induced by
micro-organisms which are commonly found in the airways
of patients with advanced COPD during stable state.16,23 In
the present study we correlated TNF-a levels in superna-
tants and AR of 24 COPD patients and we found a nonsig-
nificant correlation between AR and TNF-a (rZ 0.42,
pZ 0.07). However, TNF-a might be affected by several
factors and there are multiple and often conflicting effects
mediated by the TNF signalling in vitro which have not been
assessed in this study.15 On this basis, a larger prospective
study could clarify whether or not the increased number ofapoptotic neutrophils is due to increased induction of
apoptosis in the airways of COPD patients.
The second hypothesis that a reduced clearance of
apoptotic neutrophils from the airways in advanced COPD
results in an increased number of apoptotic neutrophils is
supported by data suggesting that inflammatory mediators
which are found in excess in the airways of COPD patients
may disrupt phagocytosis of apoptotic cells.11 Recent studies
demonstrated that the ability of macrophages to ingest
apoptotic cells in a TNF-a and oxidant-rich inflammatory
environment is impaired.24 Moreover, Noguera et al.6
reported an alteration of macrophage ability to recognize
and inactivate an apoptotic neutrophil in COPD. Thus,
apoptotic processes might be accelerated in the airways of
COPD patients, especially in those patients with the more
severe forms of the disease, either by an increased inflam-
mation that induces apoptosis of neutrophils or due to
a delayed clearance of apoptotic cells or both. We certainly
acknowledge that the present study has not assessed effer-
ocytosis which is critical for the resolution of inflammation
and this might have provided further information for the
pathogenesis of COPD. However, a prospective study is
underway to investigate this hypothesis.
In the present investigation we attempted to see
whether there is a relationship between apoptotic rates of
neutrophils and clinical parameters which may affect
apoptosis such as age. Aging is known to result in mito-
chondrial dysfunction and accumulation of macromolecular
imprints of oxidative injury which results from hydroper-
oxide-induced DNA damage.23 However, no association was
found between apoptosis and patients’ age in the present
study. This could be attributed to the fact that the range of
age of the COPD population in this study was relatively
narrow. On the other hand COPD patients were significantly
older than controls. In this respect, we cannot rule out that
age has affected the comparison of AR between patients
and controls and this might be one of the limitations of
our study.
In the present investigation we found no association
between apoptotic rates and steroids or b-agonists treat-
ment. One might have expected a significant association
between AR and steroids since steroids inhibit apoptosis of
neutrophils in vitro25 and because beta2-agonists can
potentiate corticosteroid-induced neutrophil survival at
clinically relevant drug concentrations in vitro.26 However,
steroids regulate also a variety of pro-inflammatory factors
in the cytokine network which can enhance apoptosis.27
In addition, in Pertunnen et al. study,26 the effects of
b2-agonists on spontaneous neutrophil apoptosis were
negligible. Moreover, increasing apoptotic rates of circu-
lating blood neutrophils were observed following COPD
exacerbations in a previous study where steroids and
bronchodilators were administrated as part of the treat-
ment regime.28 On this basis the effect of steroids and of
bronchodilators on apoptosis in vivo requires further
investigation considering that these pharmacologic agents
are important tools in the management of COPD.
In summary, the present study suggests that the
apoptotic rates of airway neutrophils are augmented in ex-
smoker COPD patients compared to healthy controls. In
addition, this study provides evidence that the apoptotic
rate of airway neutrophils might be associated with the
Sputum cell apoptosis in COPD 1135severity of airway obstruction which in turn might indicate
decreased clearance in patients with advanced COPD.
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